GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Aceragen Inc (FRA:V9Z) » Definitions » Shiller PE Ratio

Aceragen (FRA:V9Z) Shiller PE Ratio : (As of May. 29, 2024)


View and export this data going back to . Start your Free Trial

What is Aceragen Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Aceragen Shiller PE Ratio Historical Data

The historical data trend for Aceragen's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aceragen Shiller PE Ratio Chart

Aceragen Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Aceragen Quarterly Data
Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Aceragen's Shiller PE Ratio

For the Biotechnology subindustry, Aceragen's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Aceragen's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Aceragen's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Aceragen's Shiller PE Ratio falls into.



Aceragen Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Aceragen's E10 for the quarter that ended in Mar. 2023 is calculated as:

For example, Aceragen's adjusted earnings per share data for the three months ended in Mar. 2023 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2023 (Change)*Current CPI (Mar. 2023)
=-2.746/127.3478*127.3478
=-2.746

Current CPI (Mar. 2023) = 127.3478.

Aceragen Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201306 -15.463 98.518 -19.988
201309 -11.190 98.790 -14.425
201312 -7.942 98.326 -10.286
201403 -11.799 99.695 -15.072
201406 -10.010 100.560 -12.677
201409 -11.609 100.428 -14.721
201412 -15.441 99.070 -19.848
201503 -15.080 99.621 -19.277
201506 -13.329 100.684 -16.859
201509 -12.118 100.392 -15.372
201512 -12.485 99.792 -15.932
201603 -13.434 100.470 -17.028
201606 -13.314 101.688 -16.674
201609 -12.118 101.861 -15.150
201612 2.417 101.863 3.022
201703 -12.716 102.862 -15.743
201706 -17.400 103.349 -21.440
201709 -11.125 104.136 -13.605
201712 -8.906 104.011 -10.904
201803 -11.167 105.290 -13.507
201806 -8.586 106.317 -10.284
201809 -6.265 106.507 -7.491
201812 -6.724 105.998 -8.078
201903 -6.018 107.251 -7.146
201906 -5.868 108.070 -6.915
201909 -6.020 108.329 -7.077
201912 -26.928 108.420 -31.629
202003 3.385 108.902 3.958
202006 -10.869 108.767 -12.726
202009 -8.515 109.815 -9.874
202012 -29.485 109.897 -34.167
202103 -1.999 111.754 -2.278
202106 -2.117 114.631 -2.352
202109 -1.590 115.734 -1.750
202112 -1.204 117.630 -1.303
202203 -1.217 121.301 -1.278
202206 -1.608 125.017 -1.638
202209 -1.030 125.227 -1.047
202212 -2.924 125.222 -2.974
202303 -2.746 127.348 -2.746

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Aceragen  (FRA:V9Z) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Aceragen Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Aceragen's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Aceragen (FRA:V9Z) Business Description

Traded in Other Exchanges
N/A
Address
505 Eagleview Boulevard, Suite 212, Exton, PA, USA, 19341
Aceragen Inc is a clinical-stage biopharmaceutical company committed to transforming the care of people living with rare pulmonary and rheumatic diseases. The company portfolio includes late-stage programs based on well-established biological principles that are developing to be inventive therapeutics capable of addressing the unmet medical needs of individuals living with rare diseases.

Aceragen (FRA:V9Z) Headlines

No Headlines